Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Inspiremd Inc (NSPR)

Inspiremd Inc (NSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors GlobeNewswire - Mon Aug 4, 2025

ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST)  – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following...

RXST : 7.06 (+0.28%)
KMTS : 28.00 (+0.36%)
NSPR : 0.8600 (+0.87%)
AXNX : 70.98 (+0.75%)
InspireMD Initiates CGUARDIANS II Clinical Trial for CGuard Prime Carotid Stent System Quiver Quantitative, Inc. - Mon Dec 9, 2024

InspireMD enrolls first patient in CGUARDIANS II trial for CGuard Prime Stent System in TCAR procedures.Quiver AI SummaryInspireMD, Inc. has announced the enrollment of the first patient in its CGUARDIANS...

NSPR : 0.8600 (+0.87%)
InspireMD, Inc. Appoints Scott R. Ward to Board of Directors to Drive Stroke Prevention Innovation Quiver Quantitative, Inc. - Tue Nov 26, 2024

InspireMD appoints Scott R. Ward to its Board, enhancing expertise ahead of potential U.S. approval for CGuard Prime stent.Quiver AI SummaryInspireMD, Inc. has announced the appointment of Scott R. Ward,...

NSPR : 0.8600 (+0.87%)
NAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product Development Business Wire - Thu Sep 8, 2022

NAMSA , a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, and InspireMD, Inc . (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention...

NSPR : 0.8600 (+0.87%)

Barchart Exclusives

Why Wall Street Isn't Buying Super Micro's $60 Billion Backlog Quite Yet Barchart - 52 minutes ago
While the record backlog and strong demand are likely to translate into sustainable revenue growth, Wall Street analysts aren't bullish on SMCI stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.